Showing results (91-100 of 299) with videos related to
Sort By:
Pageof 30
European Journal of Pharmacology|November 20, 1990
Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891G J Grover, S Dzwonczyk, P G SlephJournal of Cardiovascular Pharmacology|July 1, 1985
Nitroglycerin improves the distribution of regional oxygenation in partially ischemic canine myocardiumJ Kedem, G J Grover, H R WeissResuscitation Plus|March 2, 2023
The reality of advanced airway management during out of hospital cardiac arrest; why did paramedics deviate from their allocated airway management strategy during the AIRWAYS-2 randomised trial?K Kirby, M Lazaroo, J Green, et al.Critical Care (London, England)|July 10, 2016
Increasing survival after admission to UK critical care units following cardiopulmonary resuscitationJ P Nolan, P Ferrando, J Soar, et al.Cardiovascular Research|November 1, 1992
Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoateJ A Auchampach, G J Grover, G J GrossBritish Journal of Neurosurgery|May 15, 2010
Neurosurgery as a first foundation year training postP J Grover, E A C Pereira, D PetersonBasic Research in Cardiology|March 1, 1991
The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirinG J Grover, C S Parham, W A SchumacherImmunology Letters|January 1, 1985
Monoclonal antibody associated with a lymphocyte subpopulation in chronic lymphocytic leukemiaG B Price, K Benzing, S Stewart, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|April 6, 2012
Combinations of mutant FAD2 and FAD3 genes to produce high oleic acid and low linolenic acid soybean oilAnh-Tung Pham, J Grover Shannon, Kristin D BilyeuAmerican Heart Journal|February 1, 1991
The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activatorG J Grover, C S Parham, W A SchumacherPageof 30